In section 1 of the Medicines Act 1971 (fees payable for the purposes of Part II of the Act) F1 after subsection (2) insert the following subsection—

“(2A)

In subsections (1) and (2)(b) above, any reference to a licence under Part II of the principal Act shall be taken to include a reference to a manufacturing authorisation under the Medicines for Human Use (Clinical Trials) Regulations 2004.”.